Enable Innovative Drug Discover with DEL, FBDD and SBDD
A B S T R A C T
The ability to predict chemical structure from DNA sequence has to date been a necessary cornerstone of DNAencoded
library technology. DNA-encoded libraries (DELs) are typically screened by immobilized affinity selection
and enriched library members are identified by counting the number of times an individual compound’s
sequence is observed in the resultant dataset. Those with high signal reads (DEL hits) are subsequently followed
up through off-DNA synthesis of the predicted small molecule structures. However, hits followed-up in this
manner often fail to translate to confirmed ligands. To address this low conversion rate of DEL hits to off-DNA
ligands, we have developed an approach that eliminates the reliance on chemical structure prediction from DNA
sequence. Here we describe our method of combining non-combinatorial resynthesis on-DNA following library
procedures as a rapid means to assess the probable molecules attached to the DNA barcode. Furthermore, we
apply our Bead-Assisted Ligand Isolation Mass Spectrometry (BALI-MS) technique to identify the true binders
found within the mixtures of on-DNA synthesis products. Finally, we describe a Normalized Enrichment (NE)
metric that allows for the quantitative assessment of affinity selection in these studies. We exemplify how this
combined approach enables the identification of putative hit matter against a clinically relevant therapeutic
target bisphosphoglycerate mutase, BPGM.
Bioorg. Med. Chem. 41 (2021) 116205
link:https://10.1016/j.bmc.2021.116205
HitGen Inc.
Building C2, NO.8, Huigu 1st East Road
Tianfu International Bio-Town,
Shuangliu District, Chengdu City,
Sichuan Province,P.R. China
Tel : +86-28-8519-7385
HitGen Pharmaceuticals Inc.(US Subsidiary)
Tel : +1-(508)-840-9646
Vernalis (R&D) Limited (UK Subsidiary)
Granta Park,Great Abington
Cambridge,CB21 6GB
United Kingdom
Tel : +44(0)1223-895555
We use cookies to provide a better web experience.
By using our site, you acknowledge our use of cookies and please read our Cookie Notice for
More information